Clinical Guidelines for Acute Stroke Management - Living on the EDge

References
182 The European <strong>Stroke</strong> Initiative Writing Committee and
the Writing Committee <strong>for</strong> the EUSI Executive
Committee. Recommendations <strong>for</strong> the <strong>Management</strong> of
Intracranial Haemorrhage – Part I: Spontaneous
Intracerebral Haemorrhage. Cerebrovasc Diseases.
2006;22:294-316.
183 Diez-Tejedor E, Fuentes B. Homeostasis as basis of
acute stroke treatment: <strong>Stroke</strong> units are the key.
Cerebrovascular Diseases. 2005;20(SUPPL. 2):129-34.
184 Sprigg N, Gray LJ, Bath PM, Boysen G, De Deyn PP,
Friis P, et al. Relationship between outcome and
baseline blood pressure and other haemodynamic
measures in acute ischaemic stroke: Data from the
TAIST trial. Journal of Hypertension. 2006;24(7):1413-7.
185 Sulter G, Elting JW, Langedijk M, Maurits NM, De
Keyser J. Admitting acute ischemic stroke patients to a
stroke care monitoring unit versus a conventional stroke
unit: a randomized pilot study. <strong>Stroke</strong>. 2003
Jan;34(1):101-4.
186 Silva Y, Puigdemont M, Castellanos M, Serena J, Suner
RM, Garcia MM, et al. Semi-intensive monitoring in
acute stroke and long-term outcome. Cerebrovascular
Diseases. 2005;19(1):23-30.
187 Cavallini A, Micieli G, Marcheselli S, Quaglini S. Role of
monitoring in management of acute ischemic stroke
patients. <strong>Stroke</strong>. 2003 Nov;34(11):2599-603.
188 Bennett MH, Wasiak J, Schnabel A, Kranke P, French
C. Hyperbaric oxygen therapy <strong>for</strong> acute ischaemic
stroke. Cochrane Database of Systematic Reviews
2005, Issue 3. Art. No.: CD004954. DOI:
10.1002/14651858.CD004954.pub2.
189 Singhal AB, Banner T, Roccatagliata L, Koroshetz WJ,
Schaefer PW, Lo EH, et al. A pilot study of normobaric
oxygen therapy in acute ischemic stroke. <strong>Stroke</strong>.
2005;36(4):797-802.
190 Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC.
Stress hyperglycemia and prognosis of stroke in
nondiabetic and diabetic patients: a systematic
overview. <strong>Stroke</strong>. 2001;32(10):2426-32.
191 Allport L, Baird T, Butcher K, Macgregor L, Prosser J,
Colman P, et al. Frequency and temporal profile of
poststroke hyperglycemia using continuous glucose
monitoring. Diabetes Care. 2006;29(8):1839-44.
192 Gray CS, Scott JF, French JM, Alberti KG, O'Connell JE.
Prevalence and prediction of unrecognised diabetes
mellitus and impaired glucose tolerance following acute
stroke. Age and Ageing. 2004;33(1):71-7.
193 Kernan WN, Viscoli CM, Inzucchi SE, Brass LM, Bravata
DM, Shulman GI, et al. Prevalence of abnormal glucose
tolerance following a transient ischemic attack or
ischemic stroke. Arch Intern Med. 2005;165(2):227-33.
194 Matz K, Keresztes K, Tatschl C, Nowotny M,
Dachenhausenm A, Brainin M, et al. Disorders of
glucose metabolism in acute stroke patients: an
underrecognized problem. Diabetes Care.
2006;29(4):792-7.
195 Vermeer SE, Sandee W, Algra A, Koudstaal PJ,
Kappelle LJ, Dippel DW, et al. Impaired glucose
tolerance increases stroke risk in nondiabetic patients
with transient ischemic attack or minor ischemic stroke.
<strong>Stroke</strong>. 2006;37(6):1413-7.
196 Walters MR, Weir CJ, Lees KR. A randomised,
controlled pilot study to investigate the potential benefit
of intervention with insulin in hyperglycaemic acute
ischaemic stroke patients. Cerebrovascular Diseases.
2006;22(2-3):116-22.
197 Scott JF, Robinson GM, French JM, O'Connell JE,
Alberti KGMM, Gray CS. Glucose potassium insulin
infusions in the treatment of acute stroke patients with
mild to moderate hyperglycemia: The glucose insulin in
stroke trial (GIST). <strong>Stroke</strong>. 1999;30(4):793-9.
198 Gray CS, Hildreth AJ, Sandercock PA, O'Connell JE,
Johnston DE, Cartlidge NE, et al. Glucose-potassiuminsulin
infusions in the management of post-stroke
hyperglycaemia: the UK Glucose Insulin in <strong>Stroke</strong> Trial
(GIST-UK). Lancet Neurology. 2007;6(5):397-406.
199 Ladurner G, Kalvach P, Moessler H. Neuroprotective
treatment with Cerebrolysin in patients with acute
stroke: A randomised controlled trial. Journal of Neural
Transmission. 2005;112(3):415-28.
200 Lees KR, Muir KW, Ford I, Reid L, Mendelow AD,
Sandercock PAG, et al. Magnesium <strong>for</strong> acute stroke
(Intravenous Magnesium Efficacy in <strong>Stroke</strong> trial):
Randomised controlled trial. Lancet.
2004;363(9407):439-45.
201 Krams M, Lees KR, Hacke W, Grieve AP, Orgogozo JM,
Ford GA. <strong>Acute</strong> <strong>Stroke</strong> Therapy by Inhibition of
Neutrophils (ASTIN): An Adaptive Dose-Response Study
of UK-279,276 in <strong>Acute</strong> Ischemic <strong>Stroke</strong>. <strong>Stroke</strong>.
2003;34(11):2543-8.
202 Muir KW, Lees KR. Excitatory amino acid antagonists
<strong>for</strong> acute stroke. Cochrane Database of Systematic
Reviews 2003, Issue 3. Art. No.: CD001244. DOI:
10.1002/14651858.CD001244.
203 Lees KR, Zivin JA, Ashwood T, Davalos A, Davis SM,
Diener HC, et al. NXY-059 <strong>for</strong> acute ischemic stroke.
The New England Journal of Medicine.
2006;354(6):588-600.
204 Bath PM, Sprigg N. Colony stimulating factors (including
erythropoietin, granulocyte colony stimulating factor and
analogues) <strong>for</strong> stroke. Cochrane Database of
Systematic Reviews 2007, Issue 2. Art. No.:
CD005207. DOI: 10.1002/14651858.CD005207.pub3.
205 Shyu WC, Lin SZ, Lee CC, Liu DD, Li H. Granulocyte
colony-stimulating factor <strong>for</strong> acute ischemic stroke: A
randomized controlled trial. Canadian Medical
Association Journal. 2006;174(7):927-33.
206 Bath PMW. Theophylline, aminophylline, caffeine and
analogues <strong>for</strong> acute ischaemic stroke. Cochrane
Database of Systematic Reviews 2004, Issue 3. Art.
No.: CD000211. DOI:
10.1002/14651858.CD000211.pub2.
82